Print Print Share Share #MISSING TRANSLATION: PageBar.SendToFriendTooltip# Email Large font-sizeNormal font-sizeSmall font-size

News

1 - 4 of 4 news items
  • 27 June 2011 /News - miscellaneous

    Danish Pharmacovigilance Update, 16 June 2011

    Among the articles in this issue of Danish Pharmacovigilance Update, you can read about the removal of contraindication for Velcade® (bortezomib) used for the treatment of multiple myeloma.

  • 23 June 2011 /News - miscellaneous

    Urine-derived fertility medicines are still safe

    The Danish Medicines Agency has been made aware of a recent discussion on Facebook about detection of prions (naturally occurring proteins) in urine-derived fertility medicines and a discussion of the medicine's safety. The Danish Medicines Agency advises that the prions in urine-derived fertility medicines that we referred to in our announcement on 2 May 2011 have not been associated to diseases - including the brain disease Creutzfeldt-Jakob disease.

  • 22 June 2011 /News - miscellaneous

    Indication, 27 May 2011

    The May issue of the Danish Medicines Agency's newsletter Indication has now been issued. In the newsletter, you can read that medstat.dk has been improved. It is now easier to gain access to statistics on the sale of medicines in Denmark.

  • 01 June 2011 /News - miscellaneous

    Danish Pharmacovigilance Update, May 2011

    Among the articles in this issue of Danish Pharmacovigilance Update is a status on adverse reaction reports for contraceptive pills.